Abstract:Purpose The aim of this study was to determine whether an interchromosomal effect (ICE) occurred in embryos obtained from reciprocal translocation (rcp) and Robertsonian translocation (RT) carriers who were following a preimplantation genetic diagnosis (PGD) with whole chromosome screening with an aCGH and SNP microarray. We also analyzed the chromosomal numerical abnormalities in embryos with aneuploidy in parental chromosomes that were not involved with a translocation and balanced in involved parental translocation chromosomes. Methods This retrospective study included 832 embryos obtained from rcp carriers and 382 embryos from RT carriers that were biopsied in 139 PGD cycles. The control group involved embryos obtained from age-matched patient karyotypes who were undergoing preimplantation genetic screening (PGS) with non-translocation, and 579 embryos were analyzed in the control group. A single blastomere at the cleavage stage or trophectoderm from a blastocyst was biopsied, and 24-chromosomal analysis with an aCGH/SNP microarray was conducted using the PGD/PGS protocols. Statistical analyses were implemented on the incidences of cumulative aneuploidy rates between the translocation carriers and the control group. Results Reliable results were obtained from 138 couples, among whom only one patient was a balanced rcp or RT translocation carrier, undergoing PGD testing in our center from January 2012 to June 2014. For day 3 embryos, the aneuploidy rates were 50.7% for rcp carriers and 49.1% for RT carriers, compared with the control group, with 44.8% at a maternal age < 36 years. When the maternal age was ≥ 36 years, the aneuploidy rates were increased to 61.1% for rcp carriers, 56.7% for RT carriers, and 60.3% for the control group. There were no significant differences. In day 5 embryos, the aneuploidy rates were 24.5% for rcp carriers and 34.9% for RT carriers, compared with the control group with 53.6% at a maternal age < 36 years. When the maternal age was ≥ 36 years, the aneuploidy rates were 10.7% for rcp carriers, 26.3% for RT carriers, and 57.1% for the control group. The cumulative aneuploidy rates of chromosome translocation carriers were significantly lower than the control group. No ICE was observed in cleavage and blastocyst stage embryos obtained from these carriers. Additionally, the risk of chromosomal numerical abnormalities was observed in each of the 23 pairs of autosomes or sex chromosomes from day 3 and day 5 embryos. Conclusion There was not enough evidence to prove that ICE was present in embryos derived from both rcp and RT translocation carriers, regardless of the maternal age. However, chromosomal numerical abnormalities were noticed in 23 pairs of autosomes and sex chromosomes in parental structurally normal chromosomes. Thus, 24-chromosomal analysis with an aCGH/SNP microarray PGD protocol is required to decrease the risks of failure to diagnose aneuploidy in structurally normal chromosomes.

Clinical investigation to compare aCGH and FISH in preimplantationgenetic diagnosis of chromosome translocation carriers

Using SNP array to identify aneuploidy and segmental imbalance in translocation carriers.

Application of Micro-Array Comparative Genomic Hybridization on Preimplantation Genetic Diagnosis for Chromosome Translocation

Single-nucleotide polymorphism microarray-based preimplantation genetic diagnosis is likely to improve the clinical outcome for translocation carriers.

[A Preliminary Study on the Application of Array Comparative Genomic Hybridization for Preimplantaion Genetic Diagnosis].

Preimplantation genetic diagnosis of translocation

Preimplantation genetic diagnosis of translocation]

Preliminary analysis of numerical chromosome abnormalities in reciprocal and Robertsonian translocation preimplantation genetic diagnosis cases with 24-chromosomal analysis with an aCGH/SNP microarray

Preimplantation genetic diagnosis for Robertsonian translocation carriers

[Clinical Analysis of 100 Preimplantation Genetic Diagnosis Cycles].

The Establishment and Application of Preimplantation Genetic Haplotyping in Embryo Diagnosis for Reciprocal and Robertsonian Translocation Carriers

Preimplantion genetic diagnosis with whole chromosome probes on patients who is Robertsonian translocation carrier

Clinical Application of Next-Generation Sequencing in Preimplantation Genetic Diagnosis Cycles for Robertsonian and Reciprocal Translocations

[Efficiency Comparison Between Two Preimplantation Genetic Diagnostic Methods for Chromosomal Translocation Carriers].

Strategies of PGD for female robertsonian translocation carriers:with a clinical analysis of 5 cases.

Preimplantation Genetic Testing of Robertsonian Translocation by SNP Array-Based Preimplantation Genetic Haplotyping

Preferential Selection and Transfer of Euploid Noncarrier Embryos in Preimplantation Genetic Diagnosis Cycles for Reciprocal Translocations.

Preimplantation Genetic Diagnosis for Robertsonian Translocation Carrier

Reciprocal Translocation Carrier Diagnosis in Preimplantation Human Embryos

Preimplantation genetic testing for structural rearrangement based on low-coverage next-generation sequencing accurately discriminates between normal and carrier embryos for patients with translocations

A Feasible Diagnostic Approach for the Translocation Carrier from the Indication of Products of Conception